DRE and Prostate Cancer

Friday 27th March 2020

A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA; and so a PSA alone may be falsely reassuring. Thus, a DRE can form an important part of the prostate cancer investigation process.

The examination:

All practitioners should be able to perform a DRE, as the prostate is positioned close to the anal vert, therefore the length of fingers do not restrict the examination. During a DRE, practitioners should assess the prostate to see if it is significantly:

Jagged
Hard
Irregular, as opposed to smooth.

 

Find out more:

Access GatewayC’s course ‘Prostate Cancer – Responding to a PSA Screening Request’ and collect up to 2 hours of CPD here.

Access this BMJ learning module here

Keep up to date: Twitter | Facebook | LinkedIn

Latest from the Blog

Telephone consultations: working with verbal cues

Telephone consultations: working with verbal cues

Tuesday 20th April 2021 GatewayC and the Maguire Communication Skills Training Unit have partnered to produce this resource below. Register for GatewayC Live's FREE Webinar: Effective Telephone Consultations, Wednesday 21st April 2021, 13:00 – 14:00 here What are...

read more
Could you spot bowel cancer in younger patients?

Could you spot bowel cancer in younger patients?

Monday 12th April 2021 Younger patients often do not fit the criteria for a suspected cancer pathway referral. However, every year over 2,500 younger people are diagnosed with bowel cancer in the UK. According to Bowel Cancer UK, this is only around 6% of those...

read more

Related Posts

Could you spot bowel cancer in younger patients?

Could you spot bowel cancer in younger patients?

Monday 12th April 2021 Younger patients often do not fit the criteria for a suspected cancer pathway referral. However, every year over 2,500 younger people are diagnosed with bowel cancer in the UK. According to Bowel Cancer UK, this is only around 6% of those...

read more